Hemorrhagic transformation in XXXX @entity1 .

@entity1 @entity2795 @entity64 @entity2806 @entity548
OBJECTIVE: To identify the predictors of @entity548 transformation in @entity64 @entity1 and to evaluate the impact of @entity548 transformation on rehabilitation outcome. DESIGN: The records of 203 @entity2795 @entity1 hospitalized for rehabilitation after the acute phase of @entity64 were retrospectively analyzed. In 121 cases, the first computed tomographic scan and a repeat scan were compared to determine whether @entity548 transformation occurred. Correlations between the occurrence of @entity548 transformation and use of anticoagulants, antiaggregants, and antiedema drugs were evaluated. Admission and discharge FIM trade mark and Adapted @entity1 Evaluation Conference System scores were noted, and functional gain was calculated from these. These data were also analyzed for associations with @entity548 transformation. RESULTS: Hemorrhagic transformation was detected in 39 of the 121 cases. There was no significant difference in functional outcome between @entity1 who did and did not show @entity548 transformation. Although not statistically significant, the use of antiedema drugs was found to increase the risk of @entity548 transformation, whereas the use of anticoagulants and antiaggregants had no influence. CONCLUSIONS: Hemorrhagic transformation of an @entity2806 does not affect rehabilitation outcome in @entity64 survivors. The study results favor the use of anticoagulants and antiaggregants in the acute phase unless these drugs are contraindicated by the @entity1 's condition. Still, prospective trials are needed to make definite conclusions.
